Huntington Disease Approved Drugs

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Huntington Disease.

Found 3 Approved Drugs for Huntington Disease

Xenazine

Generic Name
Tetrabenazine

Xenazine

Generic Name
Tetrabenazine
Form: Tablet
Method of administration: Oral
FDA approval date: November 24, 2008
Classification: Vesicular Monoamine Transporter 2 Inhibitor
Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington’s disease. Tetrabenazine tablets are a vesicular monoamine transporter 2 (VMAT) inhibitor indicated for the treatment of chorea associated with Huntington’s disease.

Austedo

Generic Name
Deutetrabenazine

Austedo

Generic Name
Deutetrabenazine
Form: Tablet, Kit
Method of administration: Oral
FDA approval date: April 12, 2017
AUSTEDO ® XR and AUSTEDO ® are indicated in adults for the treatment of: chorea associated with Huntington’s disease [see Clinical Studies ( 1.

Ingrezza

Generic Name
Valbenazine

Ingrezza

Generic Name
Valbenazine
Form: Kit, Capsule
Method of administration: Oral
FDA approval date: October 04, 2017
Classification: Vesicular Monoamine Transporter 2 Inhibitor
INGREZZA is indicated for the treatment of adults with: - tardive dyskinesia [see Clinical Studies ( 1.
Showing 1-3 of 3
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances